| 16 Dec, 04:02 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | nse |
| 11 Dec, 11:54 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3%". | nse |
| 11 Dec, 11:53 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 01 Dec, 06:41 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 01 Dec, 06:41 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 15 Nov, 09:15 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 15 Nov, 09:10 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 15, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg". | nse |
| 13 Nov, 11:53 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg.". | nse |
| 13 Nov, 11:45 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 11 Nov, 12:08 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 11 Nov, 12:07 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 07 Nov, 03:05 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 07 Nov, 03:04 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Sumatriptan Injection USP, 4 mg/0.5 mL and 6 mg/0.5 mL, Single-Dose Autoinjector System". | nse |
| 07 Nov, 12:37 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.". | nse |
| 07 Nov, 12:35 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 06 Nov, 09:49 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'. | nse |
| 04 Nov, 06:01 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 04 Nov, 05:57 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 04 Nov, 03:25 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a revised press release dated November 04, 2025, titled "Revised Press Release for the Q2 FY 26 Results". | nse |
| 04 Nov, 03:23 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | bse |
| 04 Nov, 02:47 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 04 Nov, 02:45 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 04 Nov, 02:43 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 Nov, 02:41 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 04, 2025, titled "Please find attached herewith the Press Release for the Q2 FY 26 Results". | nse |
| 04 Nov, 02:39 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2025. | bse |
| 04 Nov, 02:33 pm | — | … | Alembic Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. | nse |
| 04 Nov, 02:28 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2025 | bse |
| 04 Nov, 02:27 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 04, 2025. | nse |
| 29 Oct, 11:58 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Oct, 11:58 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 29, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets, 60 mg". | nse |
| 23 Oct, 12:30 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2025 | bse |
| 18 Oct, 06:02 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 18 Oct, 05:56 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 18, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Triamcinolone Acetonide Injectable Suspension USP, 40 mg/mL (Single-Dose and Multiple-Dose Vials)". | nse |
| 01 Oct, 09:52 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about General Updates - Intimation for change of email address of the Registrar and Share Transfer Agent ( RTA ) of the Company | nse |
| 25 Sept, 12:37 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 25 Sept, 12:36 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 25, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 25 mg and 37.5 mg". | nse |
| 13 Sept, 03:52 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about receipt of Establishment Inspection Report (EIR) for its API - I & API - II Facility located at Panelav | nse |
| 09 Sept, 10:50 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 09, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe". | nse |
| 09 Sept, 10:50 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |